Aims and Scope
Immuno-Oncology and Technology (IOTECH) is sister journal to Annals of Oncology and ESMO Open and the most recent addition to the European Society for Medical Oncology’s portfolio of world-class journals. By publishing high quality original research articles, reviews, perspectives, technology explained papers, letters to the editor and editorials, IOTECH aspires to provide a forum for todays’ leaders in the field of Immuno-Oncology.

Led by Editor in Chief, Professor John Haanen and an international team of expert Editors and Editorial Board members, IOTECH publishes pre-clinical and clinical studies covering natural and therapy-induced innate and adaptive immune responses against solid and haematological cancers. In addition, the journal has a strong focus on technological developments in Immuno-Oncology and seeks to highlight technological advances that decipher and improve clinical outcomes.

Advertisement